Comparison of effectiveness of caffeine with Aminophylline in treatment of prematurity apnea in preterm

Comparison of the effect of caffeine with Aminophylline in treatment of prematurity apnea in preterm neonate (<34 weeks) that admitted in NICU

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181110041605N1

Enrollment

Registered

2019-01-16

Start date

2018-03-06

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity. Respiratory disorder, unspecified

Interventions

Intervention 1: Intervention group: treatment with caffein. Intervention 2: Control group: treatment with aminophillin.

Eligibility

Sex/Gender

All

Age

1 Days to 10 Days

Inclusion criteria

Inclusion criteria: Neonate with apnea of prematurity that was GA <34 WEEK

Exclusion criteria

Exclusion criteria: Neonate with apnea of prematurity that not due to sepsis ,heart disease , hypoglycemi ,was not intuba

Design outcomes

Primary

Measure	Time frame
Recurrence of apnea. Timepoint: 72 hours after treatment. Method of measurement: Analysis of recurrence of apnea in 72 hours after treatment.	—

Secondary

Measure	Time frame
Complication of drugs and recurrence of apnea. Timepoint: 72 hours after treatment. Method of measurement: Analysis of complication of drugs in 72 hours after treatment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe jafari

Yazd University of Medical Sciences

e.jafari@ssu.ac.ir+98 35 3822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026